IGF1R and prostate carcinoma: Insulin-like growth factor I receptor (IGF1R) has also been shown to play a critical role in cancer (Peiró et al., 2009), and the inhibition of IGFR1 signaling could prevent prostate cancer cells (Fang et al., 2007).